U.S. Sponsors Of Health Insurance Lack Evidence-Based Transparency In Formulary Decisions

U.S. sponsors of health insurance lack evidence-based transparency in regard to providing reasons for their formulary decisions.

A recently published article indicates that there’s been slow uptake by sponsors of health insurance – self-funded employer groups and health plans - of a CVS Caremark formulary option, which is based on an Institute for Clinical and Economic Review (ICER) cost-effectiveness assessment of therapeutic classes with multiple competitors.